BioCentury
ARTICLE | Company News

Shire borrows $2.1B, reportedly eyes NPS

December 18, 2014 2:27 AM UTC

Shire plc (LSE:SHP; NASDAQ:SHPG) secured $2.1 billion in a revolving loan agreement amid speculation it was preparing to make an acquisition.

Both Shire and NPS Pharmaceuticals Inc. (NASDAQ:NPSP) declined to comment on media reports that Shire was mulling a bid for NPS, whose shares rose $5.63 (18%) to $36.10 on Wednesday, giving it a market cap of $3.9 billion. ...